Cuauhtémoc Oros-Ovalle
Universidad Autónoma de San Luis Potosí
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Cuauhtémoc Oros-Ovalle.
American Journal of Dermatopathology | 2011
Bertha Torres-Álvarez; Iraida G. Mesa-Garza; Juan Pablo Castanedo-Cázares; Cornelia Fuentes-Ahumada; Cuauhtémoc Oros-Ovalle; Josefina Navarrete-Solís; Benjamín Moncada
The pathogenesis of melasma has not been clearly elucidated. Using Fontana Masson; diastase-resistant periodic acid-Schiff stains; and immunohistochemistry to stem cell factor (SCF), its receptor c-kit, anti-mast cell tryptase, and anti-collagen type IV antibody, we evaluated melasma lesions and compared them with perilesional skin and photoprotected skin. Samples were taken from lesional and photoprotected nonlesional skin in 24 patients. In other 24 patients, we took biopsies of lesional and perilesional skin. With Fontana Masson, we observed many pigmented basal cells protruding into the dermis of the melasma skin. Periodic acid-Schiff stain and anti-collagen type IV showed damage on the basal membrane in 95.5% and 83%, respectively, in melasma lesion. The immunoreactivity of SCF and the prevalence of mast cells were increased in the dermis of melasma compared with perilesional dermis. The expression of c-kit was significantly increased at lesional epidermis; a frequent protrusion of c-kit-positive basal cells into the dermis was evident in 70% versus that in 29% of perilesional skin. The expression of c-kit was increased at lesional dermis of melasma compared with perilesional skin. We found a low correlation between c-kit expression and prevalence of mast cells; these were increased in melasma skin. The results may suggest a role of SCF, c-kit, and mast cells in the pathogenesis of melasma. We were surprised by the unexpected evidence of damage to basal membrane (BM), which could facilitate the fall or the migration of active melanocytes and melanin into the dermis allowing the constant hyperpigmentation in melasma.
Dermatology Research and Practice | 2011
Josefina Navarrete-Solís; Juan Pablo Castanedo-Cázares; Bertha Torres-Álvarez; Cuauhtémoc Oros-Ovalle; Cornelia Fuentes-Ahumada; Francisco Javier González; Juan David Martínez-Ramírez; Benjamín Moncada
Background. Multiple modalities have been used in the treatment of melasma with variable success. Niacinamide has anti-inflammatory properties and is able to decrease the transfer of melanosomes. Objective. To evaluate the therapeutic effect of topical niacinamide versus hydroquinone (HQ) in melasma patients. Patients and Methods. Twenty-seven melasma patients were randomized to receive for eight weeks 4% niacinamide cream on one side of the face, and 4% HQ cream on the other. Sunscreen was applied along the observation period. They were assessed by noninvasive techniques for the evaluation of skin color, as well as subjective scales and histological sections initially and after the treatment with niacinamide. Results. All patients showed pigment improvement with both treatments. Colorimetric measures did not show statistical differences between both sides. However, good to excellent improvement was observed with niacinamide in 44% of patients, compared to 55% with HQ. Niacinamide reduced importantly the mast cell infiltrate and showed improvement of solar elastosis in melasma skin. Side effects were present in 18% with niacinamide versus 29% with HQ. Conclusion. Niacinamide induces a decrease in pigmentation, inflammatory infiltrate, and solar elastosis. Niacinamide is a safe and effective therapeutic agent for this condition.
Head and Neck Pathology | 2013
Danny Soria-Céspedes; Aldo Iván Galván-Linares; Cuauhtémoc Oros-Ovalle; Francisco Gaitan-Gaona; Carlos Ortiz-Hidalgo
Synovial sarcoma (SS) arises primarily in the lower extremities with a predilection for sites in proximity to large joints, such as the knee. It rarely occurs in the head and neck region, and the tonsil is an unusual site for the tumor, with only eight previously published cases in this anatomical site. We present a case of a primary monophasic SS arising in the right tonsil in a 63-year-old male. His medical history was noncontributory. Immunohistochemistry showed that cytokeratin OSCAR, EMA, Bcl-2, vimentin, PGP 9.5, and TLE1 were diffusely positive. A molecular analysis using RT-PCR indicated that the patient was positive for the SYT/SSX1 fusion transcript. A diagnosis of monophasic synovial sarcoma of the tonsil was made.
Skin Research and Technology | 2012
Francisco Javier González; Claudio Castillo-Martínez; Marcela Martínez-Escanamé; Miguel G. Ramírez-Elías; Francisco Gaitan-Gaona; Cuauhtémoc Oros-Ovalle; Benjamín Moncada
Skin aging can be attributed to endogenous and exogenous factors which modify the hydration and protein structure of the skin which can be measured using Raman spectroscopy.
Case reports in hematology | 2015
Juan Pablo Castanedo-Cázares; Amalia Reyes-Herrera; Diana Hernández-Blanco; Cuauhtémoc Oros-Ovalle; Bertha Torres-Álvarez
Hypercalcemia in children with malignancy is an uncommon condition. It has been described in leukemia patients with impaired renal excretion of calcium or osteolytic lesions. Metastatic calcinosis cutis (MCC) may develop if hypercalcemia persists. We report the case of a 5-year-old girl with an atypical dermatosis and unspecific gastrointestinal symptoms. Considered clinical diagnoses were xanthomas, histiocytosis, molluscum contagiosum, and nongenital warts. Cutaneous histological analysis showed amorphous basophilic deposits in the dermis suggestive of calcium deposits. Laboratory tests confirmed serum hypercalcemia. Extensive investigations such as bone marrow biopsy established the diagnosis of an acute pre-B cell lymphoblastic leukemia. Hypercalcemia in hematopoietic malignancies is unusual, especially as initial manifestation of the disease. Careful review of the literature fails to reveal previous reports of these peculiar cutaneous lesions of MCC in children with leukemia.
Reumatología Clínica | 2013
Marco Ulises Martínez-Martínez; Alejandro Gómez-Gómez; Cuauhtémoc Oros-Ovalle; Carlos Abud-Mendoza
Gaceta Medica De Mexico | 2004
B Cesáreo; Costero-Barrios; Cuauhtémoc Oros-Ovalle
Revista médica del Instituto Mexicano del Seguro Social | 2013
Marco Ulises Martínez-Martínez; Susana Román-Acosta; Alvarez-Reyes Jm; Cuauhtémoc Oros-Ovalle; Carlos Abud-Mendoza
Reumatología Clínica | 2013
Marco Ulises Martínez-Martínez; Alejandro Gómez-Gómez; Cuauhtémoc Oros-Ovalle; Carlos Abud-Mendoza
Revista médica del Instituto Mexicano del Seguro Social | 2016
Adriana Rodríguez-Arámbula; Elsa Arenas-Velázquez; Juan Pablo Castanedo-Cázares; Diana Hernández-Blanco; Cuauhtémoc Oros-Ovalle; Bertha Torres-Álvareza